PM
Parametrica Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Hold |
195,878
| – | – | 0.63% | 20 |
|
|
2025
Q1 | $652K | Sell |
195,878
-65,212
| -25% | -$217K | 1.1% | 17 |
|
|
2024
Q4 | $1.93M | Hold |
261,090
| – | – | 2.55% | 11 |
|
|
2024
Q3 | $2.45M | Hold |
261,090
| – | – | 2.92% | 10 |
|
|
2024
Q2 | $2.09M | Buy |
261,090
+129,500
| +98% | +$1.04M | 2.77% | 14 |
|
|
2024
Q1 | $1.95M | Sell |
131,590
-188,686
| -59% | -$2.8M | 2.81% | 12 |
|
|
2023
Q4 | $2.6M | Buy |
320,276
+224,876
| +236% | +$1.83M | 4.27% | 6 |
|
|
2023
Q3 | $434K | Sell |
95,400
-1,100
| -1% | -$5.01K | 0.73% | 27 |
|
|
2023
Q2 | $679K | Buy |
96,500
+47,800
| +98% | +$337K | 1.31% | 22 |
|
|
2023
Q1 | $298K | Buy |
48,700
+800
| +2% | +$4.89K | 0.54% | 21 |
|
|
2022
Q4 | $306K | Sell |
47,900
-46,750
| -49% | -$298K | 0.63% | 29 |
|
|
2022
Q3 | $907K | Sell |
94,650
-21,220
| -18% | -$203K | 1.85% | 13 |
|
|
2022
Q2 | $1.27M | Sell |
115,870
-18,809
| -14% | -$206K | 1.38% | 19 |
|
|
2022
Q1 | $2.24M | Sell |
134,679
-14,502
| -10% | -$241K | 1.66% | 12 |
|
|
2021
Q4 | $2.85M | Buy |
149,181
+2,819
| +2% | +$53.8K | 2.83% | 12 |
|
|
2021
Q3 | $3.61M | Buy |
146,362
+72,087
| +97% | +$1.78M | 2.7% | 11 |
|
|
2021
Q2 | $1.93M | Buy |
+74,275
| New | +$1.93M | 1.43% | 25 |
|
|
2020
Q3 | – | Sell |
-8,754
| Closed | -$240K | – | 120 |
|
|
2020
Q2 | $240K | Buy |
+8,754
| New | +$240K | 0.26% | 93 |
|